Cargando…

The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada

BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Kevin A., Soucy, Jean-Paul R., Buchan, Sarah A., Sturrock, Shelby L., Berry, Isha, Stall, Nathan M., Jüni, Peter, Ghasemi, Amir, Gibb, Nicholas, MacFadden, Derek R., Daneman, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Joule Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101979/
https://www.ncbi.nlm.nih.gov/pubmed/33827852
http://dx.doi.org/10.1503/cmaj.210132
_version_ 1783689037975912448
author Brown, Kevin A.
Soucy, Jean-Paul R.
Buchan, Sarah A.
Sturrock, Shelby L.
Berry, Isha
Stall, Nathan M.
Jüni, Peter
Ghasemi, Amir
Gibb, Nicholas
MacFadden, Derek R.
Daneman, Nick
author_facet Brown, Kevin A.
Soucy, Jean-Paul R.
Buchan, Sarah A.
Sturrock, Shelby L.
Berry, Isha
Stall, Nathan M.
Jüni, Peter
Ghasemi, Amir
Gibb, Nicholas
MacFadden, Derek R.
Daneman, Nick
author_sort Brown, Kevin A.
collection PubMed
description BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to control SARS-CoV-2 (i.e., mobility threshold), and the difference relative to the observed mobility level (i.e., mobility gap). METHODS: We conducted a time-series study of the weekly incidence of SARS-CoV-2 in Canada from Mar. 15, 2020, to Mar. 6, 2021. The outcome was weekly growth rate, defined as the ratio of cases in a given week versus the previous week. We evaluated the effects of average time spent outside the home in the previous 3 weeks using a log-normal regression model, accounting for province, week and mean temperature. We calculated the SARS-CoV-2 mobility threshold and gap. RESULTS: Across the 51-week study period, a total of 888 751 people were infected with SARS-CoV-2. Each 10% increase in the mobility gap was associated with a 25% increase in the SARS-CoV-2 weekly case growth rate (ratio 1.25, 95% confidence interval 1.20–1.29). Compared to the prepandemic baseline mobility of 100%, the mobility threshold was highest in the summer (69%; interquartile range [IQR] 67%–70%), and dropped to 54% in winter 2021 (IQR 52%–55%); a mobility gap was present in Canada from July 2020 until the last week of December 2020. INTERPRETATION: Mobility strongly and consistently predicts weekly case growth, and low levels of mobility are needed to control SARS-CoV-2 through spring 2021. Mobility measures from anonymized smartphone data can be used to guide provincial and regional loosening and tightening of physical distancing measures.
format Online
Article
Text
id pubmed-8101979
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher CMA Joule Inc.
record_format MEDLINE/PubMed
spelling pubmed-81019792021-05-07 The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada Brown, Kevin A. Soucy, Jean-Paul R. Buchan, Sarah A. Sturrock, Shelby L. Berry, Isha Stall, Nathan M. Jüni, Peter Ghasemi, Amir Gibb, Nicholas MacFadden, Derek R. Daneman, Nick CMAJ Research BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to control SARS-CoV-2 (i.e., mobility threshold), and the difference relative to the observed mobility level (i.e., mobility gap). METHODS: We conducted a time-series study of the weekly incidence of SARS-CoV-2 in Canada from Mar. 15, 2020, to Mar. 6, 2021. The outcome was weekly growth rate, defined as the ratio of cases in a given week versus the previous week. We evaluated the effects of average time spent outside the home in the previous 3 weeks using a log-normal regression model, accounting for province, week and mean temperature. We calculated the SARS-CoV-2 mobility threshold and gap. RESULTS: Across the 51-week study period, a total of 888 751 people were infected with SARS-CoV-2. Each 10% increase in the mobility gap was associated with a 25% increase in the SARS-CoV-2 weekly case growth rate (ratio 1.25, 95% confidence interval 1.20–1.29). Compared to the prepandemic baseline mobility of 100%, the mobility threshold was highest in the summer (69%; interquartile range [IQR] 67%–70%), and dropped to 54% in winter 2021 (IQR 52%–55%); a mobility gap was present in Canada from July 2020 until the last week of December 2020. INTERPRETATION: Mobility strongly and consistently predicts weekly case growth, and low levels of mobility are needed to control SARS-CoV-2 through spring 2021. Mobility measures from anonymized smartphone data can be used to guide provincial and regional loosening and tightening of physical distancing measures. CMA Joule Inc. 2021-04-26 /pmc/articles/PMC8101979/ /pubmed/33827852 http://dx.doi.org/10.1503/cmaj.210132 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Brown, Kevin A.
Soucy, Jean-Paul R.
Buchan, Sarah A.
Sturrock, Shelby L.
Berry, Isha
Stall, Nathan M.
Jüni, Peter
Ghasemi, Amir
Gibb, Nicholas
MacFadden, Derek R.
Daneman, Nick
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
title The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
title_full The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
title_fullStr The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
title_full_unstemmed The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
title_short The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
title_sort mobility gap: estimating mobility thresholds required to control sars-cov-2 in canada
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101979/
https://www.ncbi.nlm.nih.gov/pubmed/33827852
http://dx.doi.org/10.1503/cmaj.210132
work_keys_str_mv AT brownkevina themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT soucyjeanpaulr themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT buchansaraha themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT sturrockshelbyl themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT berryisha themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT stallnathanm themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT junipeter themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT ghasemiamir themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT gibbnicholas themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT macfaddenderekr themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT danemannick themobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT brownkevina mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT soucyjeanpaulr mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT buchansaraha mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT sturrockshelbyl mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT berryisha mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT stallnathanm mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT junipeter mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT ghasemiamir mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT gibbnicholas mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT macfaddenderekr mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada
AT danemannick mobilitygapestimatingmobilitythresholdsrequiredtocontrolsarscov2incanada